References
- Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD); 2020 [cited 2020 Apr 23]. Available from: http://www.goldcopd.org
- Agustí AG. Systemic effects of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2(4):367–370. DOI:https://doi.org/10.1513/pats.200504-026SR
- Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33(5):1165–1185. DOI:https://doi.org/10.1183/09031936.00128008
- Bernardo I, Bozinovski S, Vlahos R. Targeting oxidant-dependent mechanisms for the treatment of COPD and its comorbidities. Pharmacol Ther. 2015;155:60–79. DOI:https://doi.org/10.1016/j.pharmthera.2015.08.005
- Cazzola M, Bettoncelli G, Sessa E, et al. Prevalence of comorbidities in patients with chronic obstructive pulmonary disease. Respiration. 2010;80(2):112–119. DOI:https://doi.org/10.1159/000281880
- Yin HL, Yin SQ, Lin QY, et al. Prevalence of comorbidities in chronic obstructive pulmonary disease patients: a meta-analysis. Medicine (Baltimore). 2017;96(19):e6836. DOI:https://doi.org/10.1097/MD.0000000000006836
- Mannino DM, Thorn D, Swensen A, et al. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008;32(4):962–969. DOI:https://doi.org/10.1183/09031936.00012408
- Crook M. Type 2 diabetes mellitus: a disease of the innate immune system? An update. Diabet Med. 2004;21(3):203–207. DOI:https://doi.org/10.1046/j.1464-5491.2003.01030.x
- Festa A, D’Agostino R, Howard G, et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000;102(1):42–47. DOI:https://doi.org/10.1161/01.CIR.102.1.42
- Zaigham S, Nilsson PM, Wollmer P, et al. The temporal relationship between poor lung function and the risk of diabetes. BMC Pulm Med. 2016;16(1):75. DOI:https://doi.org/10.1186/s12890-016-0227-z
- Ho TW, Huang CT, Ruan SY, et al. Diabetes mellitus in patients with chronic obstructive pulmonary disease-The impact on mortality. PLoS One. 2017;12(4):e0175794. DOI:https://doi.org/10.1371/journal.pone.0175794
- Bunn HF, Haney DN, Kamin S, et al. The biosynthesis of human hemoglobin A1c. Slow glycosylation of hemoglobin in vivo. J Clin Invest. 1976;57(6):1652–1659. DOI:https://doi.org/10.1172/JCI108436
- Yang CJ, Liao WI, Tang ZC, et al. Glycated hemoglobin A1c-based adjusted glycemic variables in patients with diabetes presenting with acute exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2017;12:1923–1932. DOI:https://doi.org/10.2147/COPD.S131232
- Roberts GW, Quinn SJ, Valentine N, et al. Relative hyperglycemia, a marker of critical illness: introducing the stress hyperglycemia ratio. J Clin Endocrinol Metab. 2015;100(12):4490–4497. DOI:https://doi.org/10.1210/jc.2015-2660
- Chen PC, Liao WI, Wang YC, et al. An elevated glycemic gap is associated with adverse outcomes in diabetic patients with community-acquired pneumonia. Medicine (Baltimore). 2015;94(34):e1456. DOI:https://doi.org/10.1097/MD.0000000000001456
- Liao WI, Lin CS, Lee CH, et al. An elevated glycemic gap is associated with adverse outcomes in diabetic patients with acute myocardial infarction. Sci Rep. 2016;6:27770. DOI:https://doi.org/10.1038/srep27770
- Liao WI, Wang JC, Chang WC, et al. Usefulness of glycemic gap to predict ICU mortality in critically ill patients with diabetes. Medicine (Baltimore). 2015;94(36):e1525. DOI:https://doi.org/10.1097/MD.0000000000001525
- 6. Glycemic targets: standards of medical care in diabetes-2019. Diabetes Care. 2019;42:S61–S70.
- Ramaraju K, Kaza AM, Balasubramanian N, et al. Predicting healthcare utilization by patients admitted for COPD exacerbation. J Clin Diagn Res. 2016;10(2):OC13–OC17. DOI:https://doi.org/10.7860/JCDR/2016/17721.7216
- Li CI, Li TC, Liu CS, et al. Extreme values of hemoglobin a1c are associated with increased risks of chronic obstructive pulmonary disease in patients with type 2 diabetes: a competing risk analysis in national cohort of Taiwan diabetes study. Medicine (Baltimore). 2015;94(1):e367. DOI:https://doi.org/10.1097/MD.0000000000000367
- Kanazawa H, Asai K, Hirata K, et al. Possible effects of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease. Am J Med. 2003;114(5):354–358. DOI:https://doi.org/10.1016/S0002-9343(02)01562-0
- Kasahara Y, Tuder RM, Cool CD, et al. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med. 2001;163(3):737–744. DOI:https://doi.org/10.1164/ajrccm.163.3.2002117
- Egi M, Bellomo R, Stachowski E, et al. The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes. Crit Care Med. 2011;39:105–111.
- Parappil A, Depczynski B, Collett P, et al. Effect of comorbid diabetes on length of stay and risk of death in patients admitted with acute exacerbations of COPD. Respirology. 2010;15(6):918–922. DOI:https://doi.org/10.1111/j.1440-1843.2010.01781.x
- Gudmundsson G, Ulrik CS, Gislason T, et al. Long-term survival in patients hospitalized for chronic obstructive pulmonary disease: a prospective observational study in the Nordic countries. Int J Chron Obstruct Pulmon Dis. 2012;7:571–576.
- Rao Kondapally Seshasai S, Kaptoge S, Thompson A, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364(9):829–841. DOI:https://doi.org/10.1056/NEJMoa1008862
- Baker EH, Janaway CH, Philips BJ, et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax. 2006;61(4):284–289. DOI:https://doi.org/10.1136/thx.2005.051029
- Moretti M, Cilione C, Tampieri A, et al. Incidence and causes of non-invasive mechanical ventilation failure after initial success. Thorax. 2000;55(10):819–825. DOI:https://doi.org/10.1136/thorax.55.10.819
- Robinson LE, van Soeren MH. Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic control. AACN Clin Issues. 2004;15(1):45–62. DOI:https://doi.org/10.1097/00044067-200401000-00004
- Donagaon S, Dharmalingam M. Association between glycemic gap and adverse outcomes in critically ill patients with diabetes. Indian J Endocr Metab. 2018;22(2):208–211. DOI:https://doi.org/10.4103/ijem.IJEM_580_17
- Bafadhel M, Greening NJ, Harvey-Dunstan TC, et al. Blood eosinophils and outcomes in severe hospitalized exacerbations of COPD. Chest. 2016;150(2):320–328. DOI:https://doi.org/10.1016/j.chest.2016.01.026
- Bafadhel M, McKenna S, Terry S, et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med. 2011;184(6):662–671. DOI:https://doi.org/10.1164/rccm.201104-0597OC
- Jabarkhil A, Moberg M, Janner J, et al. Elevated blood eosinophils in acute COPD exacerbations: better short- and long-term prognosis. Eur Clin Respir J. 2020;7(1):1757274. DOI:https://doi.org/10.1080/20018525.2020.1757274
- Saltürk C, Karakurt Z, Adiguzel N, et al. Does eosinophilic COPD exacerbation have a better patient outcome than non-eosinophilic in the intensive care unit? Int J Chron Obstruct Pulmon Dis. 2015;10:1837–1846.
- Steer J, Gibson J, Bourke SC. The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax. 2012;67(11):970–976. DOI:https://doi.org/10.1136/thoraxjnl-2012-202103
- Holland M, Alkhalil M, Chandromouli S, et al. Eosinopenia as a marker of mortality and length of stay in patients admitted with exacerbations of chronic obstructive pulmonary disease. Respirology. 2010;15(1):165–167. DOI:https://doi.org/10.1111/j.1440-1843.2009.01651.x
- Koskela HO, Salonen PH, Romppanen J, et al. A history of diabetes but not hyperglycaemia during exacerbation of obstructive lung disease has impact on long-term mortality: a prospective, observational cohort study. BMJ Open. 2015;5(1):e006794. DOI:https://doi.org/10.1136/bmjopen-2014-006794
- Bishwakarma R, Zhang W, Lin YL, et al. Metformin use and health care utilization in patients with coexisting chronic obstructive pulmonary disease and diabetes mellitus. COPD. 2018;13:793–800. DOI:https://doi.org/10.2147/COPD.S150047